Cytotoxic effects of catechol to neuroblastoma N2a cells

General Physiology and Biophysics

Volumn 27, Issue 4, 2008, Pages 306-314

  Lima, Rute M F ^a   Alvarez, Lisandro D G ^a   Costa, Maria F D ^a   Costa, Silvia L ^a   Clarêncio, Jorge ^b   El Bachá, Ramon S ^a  

^a Laboratory of Neurochemistry and Cell Biology   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Apoptosis; Catechol; Cytotoxicity; Glutathione; Neuroblastoma

Indexed keywords

ACETYLCYSTEINE; CATALASE; CATECHOL; CYSTEINE; DEFEROXAMINE; GLUTATHIONE; I KAPPA B; IRON; LIPOCORTIN 5; MONOCHLOROBIMANE; PROPIDIUM IODIDE; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; REAGENT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CELL DEATH; CELL METABOLISM; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY TEST; FLOW CYTOMETRY; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; STAINING;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; ASCORBIC ACID; CATECHOLS; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; CYSTEINE; CYTOTOXINS; DEFEROXAMINE; GLUTATHIONE; MICE; NEUROBLASTOMA; NF-KAPPA B; REACTIVE OXYGEN SPECIES; SESQUITERPENES; SUPEROXIDE DISMUTASE;

EID: 60149097996     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Almeida W. L. C., Vítor D. N., Pereira M. R. G., de Sá D. S., Alvarez L. D. G., Pinheiro A. M., Costa S. L., Costa M. F. D., da Rocha Z. N., El-Bachá R. S. (2007): Redox properties of ruthenium complex with catechol are involved in toxicity to glial cells. J. Chil. Chem. Soc. 52, 1240-1243
2. Atkinson T. J. (2008): A review of the role of benzene metabolites and mechanisms in malignant transformation: Summative evidence for a lack of research in nonmyelogenous cancer types. Int. J. Hyg. Environ. Health (doi:10.1016/j.ijheh.2007.09.013)
3. Barreto G. E. S., de Oliveira E. S., de Villar F. A. G. A., dos Santos G. S., Lima R. M. F., Costa S. L., Costa M. F. D., Egito E. S. T., El-Bachá R. S. (2007): Investigation of toxic factors affecting cells of rat brains exposed to 3-methylcatechol. Braz. Arch. Biol. Technol. 50, 839-849
4. Bergeron Jr. R. J. (2006): Polyamine-metal chelator conjugates. U.S. Pat. Appl. 20060211773
5. Bermond II D. M., Tose H. (2000): Alcohol use: interactions with benzene and other substances at workplace. Rev. Psiq. Clín. 27, (in Portuguese), http://www.hcnet.usp.br/ipq/revista/vol27/n2/art65.htm
6. Bledig S. A., Byrum J. R., Lyu J. (2008): Nucleic acid molecules and other molecules associated with the methionine synthesis and degradation pathways. U.S. Pat. Appl. 20080005809
7. Chiang P. K., Levy D. E., Guo M., Martichonok V. V., Sefton B.A. (2007): Methods and compositions for treating diseases associated with pathogenic proteins. U.S. Pat. Appl. 20070179123
8. Chichirau A., Flueraru M., Chepelev L. L., Wright J. S., Willmore W. G., Durst T., Hussain H. H., Charron M. (2005): Mechanism of cytotoxicity of catechols and a naphthalenediol in PC12-AC cells: the connection between extracellular autoxidation and molecular electronic structure. Free Radic. Biol. Med. 38, 344-355
9. 2 cytotoxicity. In: The 11th Meeting of the International Neurotoxicology Association. (Eds. L. Fechter, M. Aschner, D. Fox and I. Pessah), pp. 35, International Neurotoxicology Association, Pacific Grove
10. Elenbaas B., Jarpe M. B., Mildasz S. D., Fawell S. E. (2007): Antibodies to the human prolactin receptor. U.S. Pat. Appl. 20070269438
11. Fan H., Peng J., Hamann M. T., Hu J. F. (2008): Lamellarins and related pyrrole-derived alkaloids from marine organisms. Chem. Rev. 108, 264-287
12. Gabryel B., Malecki A. (2006): Ebselen attenuates oxidative stress in ischemic astrocytes depleted of glutathione. Comparison with glutathione precursors. Pharmacol. Rep. 58 (Suppl. 1), 381-392
13. Hamner J. B., Sims T. L., Cutshaw A., Dickson P. V., Rosati S., McGee M., Ng C. Y., Davidoff A. M. (2008): The efficacy of combination therapy using adeno-associated virus-interferon β and trichostatin A in vitro and in a murine model of neuroblastoma. J. Pediatr. Surg. 43, 177-183
14. Isbell M. A., Stolzberg R. J., Duffy L. K. (2005): Indoor climate in interior Alaska: simultaneous measurement of ventilation, benzene and toluene in residential indoor air of two homes. Sci. Total Environ. 345, 31-40
15. Kubota R. (2008): Extended primary retinal cell culture and stress models, and methods of use. U.S. Pat. Appl. 20080003634
16. Lansbury P. T., Liu Z. (2007): Methods for the treatment of synucleinopathies. U.S. Pat. Appl. 20070293539
17. Law C.-L., McEarchern J., Wahl A. F. (2007): Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders. U.S. Pat. Appl. 20070292422
18. Lazar G. A., Dang W., Desjarlais J. R., Karki S. B., Vafa O., Hayes R. (2007a): Fc variants having decreased affinity for Fcy RIIc. U.S. Pat. Appl. 20070238665
19. Lazar G. A., Dang W., Desjarlais J. R., Karki S. B., Vafa O., Hayes R. (2007b): Fc variants having increased affinity for Fcy RIIc. U.S. Pat. Appl. 20070248602
20. Lazar G. A., Dang W., Desjarlais J. R., Karki S. B., Vafa O., Hayes R. (2007c): Fc variants having decreased affinity for Fcy RI. U.S. Pat. Appl. 20070286859
21. Lazar G. A., Chirino A. J., Dang W., Desjarlais J. R., Doberstein S. K., Hayes R. J., Karki S. B., Vafa O. (2008): Optimized Fc variants. U.S. Pat. 7317091
22. Leone G., Pagano L., Ben-Yehuda D., Voso M. T. (2007): Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica 92, 1389-1398
23. Lo Y.-C., Liu Y., Lin Y.-C., Shih Y.-T., Liu C.-M., Burka L. T. (2008): Neuronal effects of 4-t-butylcatechol: a model for catechol-containing antioxidants. Toxicol. Appl. Pharmacol. 228, 247-255
24. Mohrlüder J., Stangler T., Hoffmann Y., Wiesehan K., Mataruga A., Willbold D. (2007): Identification of calreticulin as a ligand of GABARAP by phage display screening of a peptide library. FEBS J. 274, 5543-5555
25. Movsesyan V. A., Yakovtev A. G., Dabaghyan E. A., Stoica B. A., Faen A. I. (2002): Ceramide induces neuronal apoptosis through the caspase-9/ caspase-3 pathway. Biochem. Biophys. Res. Commun. 299, 201-207
26. Padigaru M. (2006): Nucleic acid encoding a NOVX13 polypeptide. U.S. Pat. 7122345
27. Pereira M. R. G., de Oliveira E. S., de Villar F. A. G. A., Grangeiro M. S., Fonseca J., Silva A. R., Costa M. F. D., Costa S. L., El-Bachá R. S. (2004): Cytotoxicity of catechol towards human glioblastoma cells via superoxide and reactive quinones generation. J. Bras. Patol. Med. Lab. 40, 280-285
28. Snyder R., Dimitriadis E., Guy R., Hu P., Cooper K., Bauer H., Witz G., Goldstein B. D. (1989): Studies on the mechanism of benzene toxicity. Environ. Health Perspect. 82, 31-35
29. Welch E., Zhuo J. (2007): Methods for identifying small molecules that modulate premature translation termination and nonsense mRNA decay. U.S. Pat. 7291461
30. Youdim M., Fridkin M., Zheng H., Warshawsky A., Warshawsky R. (2006): Neuroprotective iron chelators and pharmaceutical compositions comprising them. U.S. Pat. Appl. 20060234927